International Journal of Nanomedicine · 2017 · 15 citations · 33 references
Natural SciencesBioengineeringBiotechnologyBiocompatibilityBiomaterialsTissue EngineeringAntimicrobial BiomaterialsBioceramicsBiomaterials For Oral RegenerationBiomaterials For Tissue EngineeringNanostructured BiomaterialsNatural BiomaterialsAntibacterial BiocompatibilityAntibacterial NanocoatingsBioactive NanocoatingsCellular Inflammatory ResponsesInflammatory Cellular ChangesOsteogenic MarkersPro-inflammatory Cytokine ExpressionProinflammatory Mediators
Background: Bioengineered plant-derived Rhamnogalacturonan-Is (RG-Is) from pectins are potential candidates for surface nanocoating of medical devices. It has recently been reported that RG-I nanocoatings may prevent bacterial infection and improve the biocompatibility of implants. The aim of the study was to evaluate in vitro impact of bioengineered RG-I nanocoatings on osteogenic capacity and proinflammatory cytokine response of murine osteoblasts following Porphyromonas gingivalis infection. Methods: Murine MC3T3-E1 osteoblasts and isolated primary calvarial osteoblasts from C57BL/6J (B6J osteoblasts) mice were infected with P . gingivalis and incubated on tissue culture polystyrene plates with or without nanocoatings of unmodified RG-Is isolated from potato pulps (PU) or dearabinanated RG-Is (PA). To investigate a behavior of infected osteoblasts cultured on RG-Is cell morphology, proliferation, metabolic activity, mineralization and osteogenic and pro-inflammatory gene expression were examined. Results: Following P . gingivalis infection, PA, but not PU, significantly promoted MC3T3-E1 and BJ6 osteoblasts proliferation, metabolic activity, and calcium deposition. Moreover, Il-1b , Il-6 , TNF-α , and Rankl gene expressions were downregulated in cells cultured on PU and to a higher extent on PA as compared to the corresponding control, whereas Runx , Alpl , Col1a1 , and Bglap gene expressions were upregulated vice versa. Conclusion: Our data clearly showed that pectin RG-Is nanocoating with high content of galactan (PA) reduces the osteoblastic response to P . gingivalis infection in vitro and may, therefore, reduce a risk of inflammation especially in immunocompromised patients with rheumatoid or periodontal disorders. Keywords: nanocoatings, Rhamnogalacturonan-I, Porphyromonas gingivalis , osteoblasts, inflammation
33
IL-6 is produced by osteoblasts and induces bone resorption.
Yoshiko Ishimi, Chisato Miyaura, Cheng Jin et al. · The Journal of Immunology · 1990 · 1.1K citations
Medicine, Endocrinology, Immunology +14
Association of Periodontitis With Rheumatoid Arthritis: A Pilot Study
Addie Dissick, Robert S. Redman, Miata Jones et al. · Journal of Periodontology · 2010 · 264 citations
Hirohito Kato, Yoichiro Taguchi, Kazuya Tominaga et al. · Archives of Oral Biology · 2013 · 210 citations